PMID- 33214593 OWN - NLM STAT- MEDLINE DCOM- 20210113 LR - 20210113 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 10 IP - 1 DP - 2020 Nov 19 TI - Efficacy of P(11)-4 for the treatment of initial buccal caries: a randomized clinical trial. PG - 20211 LID - 10.1038/s41598-020-77057-3 [doi] LID - 20211 AB - To investigate the safety and efficacy of Self-Assembling Peptide P(11)-4 (SAP P(11)-4) compared to placebo or fluoride varnish (FV), a randomized, controlled, blinded, split-mouth study with sequential design was conducted. Subjects presenting two teeth with White-Spot-Lesions (WSLs) were included and teeth were randomly assigned to test or control. Control received placebo at baseline (D0) and test SAP P(11)-4, all received FV at Day 90 (D90). Standardized photographs were taken at each visit, and WSL size changes were morphometrically assessed. Hierarchical Linear Modelling, considering paired and sequential design, was used to test four hypotheses. SAP P(11)-4 lesions (test, D90-D0) showed significant WSL size reduction compared to placebo (control, D90-D0; p = 0.008) or FV (control, D180-D90; p = 0.001). Combination of SAP P(11)-4 and delayed FV after 90 days (test, D180-D0), showed a significant difference compared to FV alone (control D270-D90; p = 0.003). No significant difference on FV efficacy was found when SAP P(11)-4 was applied 3 months before FV (test D270-D90; control D270-D90, p = 0.70). SAP P(11)-4 treatment resulted in superior caries regression compared to either placebo or FV, and FV efficacy seems not to be affected by SAP P(11)-4. SAP P(11)-4 was found to be a safe and effective WSL treatment. FAU - Sedlakova Kondelova, Paulina AU - Sedlakova Kondelova P AD - University of Geneva, University Dental Clinics CUMD, rue Michel-Servet 1, 1211, Geneva 4, Switzerland. FAU - Mannaa, Alaa AU - Mannaa A AD - Division of Operative Dentistry, Department of Restorative Dentistry, Faculty of Dentistry, King Abdulaziz University, P.O. Box 80209, Jeddah, 21589, Kingdom of Saudi Arabia. FAU - Bommer, Claudine AU - Bommer C AD - Credentis AG, Dorfstrasse 69, 5210, Windisch, Switzerland. FAU - Abdelaziz, Marwa AU - Abdelaziz M AD - University of Geneva, University Dental Clinics CUMD, rue Michel-Servet 1, 1211, Geneva 4, Switzerland. FAU - Daeniker, Laurent AU - Daeniker L AD - University of Geneva, University Dental Clinics CUMD, rue Michel-Servet 1, 1211, Geneva 4, Switzerland. FAU - di Bella, Enrico AU - di Bella E AD - Department of Political Sciences, University of Genova, P.le E. Brignole 3a, 16126, Genova, Italy. FAU - Krejci, Ivo AU - Krejci I AD - University of Geneva, University Dental Clinics CUMD, rue Michel-Servet 1, 1211, Geneva 4, Switzerland. Ivo.Krejci@unige.ch. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20201119 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Cariostatic Agents) RN - 0 (Fluorides, Topical) RN - 0 (Oligopeptides) RN - 0 (P11-4 peptide) SB - IM MH - Adolescent MH - Adult MH - Cariostatic Agents/*therapeutic use MH - Dental Caries/*drug therapy MH - Female MH - Fluorides, Topical/*therapeutic use MH - Humans MH - Male MH - Oligopeptides/*therapeutic use MH - Treatment Outcome MH - Young Adult PMC - PMC7678830 COIS- C. Bommer is an employee of credentis. All other authors declare no competing interests. EDAT- 2020/11/21 06:00 MHDA- 2021/01/14 06:00 PMCR- 2020/11/19 CRDT- 2020/11/20 05:46 PHST- 2020/05/05 00:00 [received] PHST- 2020/10/09 00:00 [accepted] PHST- 2020/11/20 05:46 [entrez] PHST- 2020/11/21 06:00 [pubmed] PHST- 2021/01/14 06:00 [medline] PHST- 2020/11/19 00:00 [pmc-release] AID - 10.1038/s41598-020-77057-3 [pii] AID - 77057 [pii] AID - 10.1038/s41598-020-77057-3 [doi] PST - epublish SO - Sci Rep. 2020 Nov 19;10(1):20211. doi: 10.1038/s41598-020-77057-3.